Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 USD | -3.22% | +2.85% | +572.25% |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+572.25% | 204M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Wedbush Raises Elevation Oncology's PT to $8 From $5, Continues to See 'Intriguing' Opportunity in Shares; Keeps Outperform Rating